Who this is for: State and local health departments and acute care hospitals that may serve as Ebola assessment hospitals.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans for patients under investigation (PUIs) for Ebola virus disease (EVD).
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts to prepare hospitals identified as Ebola assessment hospitals and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) and Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Treatment Centers and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation for Ebola Virus Disease.
Who this is for: State and local health departments and acute care hospitals that may serve as Ebola assessment hospitals.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans for patients under investigation (PUIs) for Ebola virus disease (EVD).
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts to prepare hospitals identified as Ebola assessment hospitals and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) and Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Treatment Centers and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation for Ebola Virus Disease.